About Kadmon

Kadmon is a global biopharmaceutical company built on a 21st-century paradigm for the translation of innovative science into treatment. The company currently offers products and services for the treatment and management of hepatitis C. Kadmon is pioneering medicines in oncology, infectious diseases, immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. Kadmon’s strategy breaks from the costly, time-consuming and inefficient drug development models of the past by leveraging its growing, specialist-driven commercial platform to advance a pipeline of novel small molecules and biologics. By challenging how treatments for serious diseases are developed today, Kadmon is developing the cures of tomorrow.

Kadmon Corporation, LLC is headquartered in New York City with operations in Warrendale, PA and Boston, MA.